Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19

View ORCID ProfileAugust Jernbom Falk, Lovisa Skoglund, Elisa Pin, Ronald Sjöberg, Hanna Tegel, Sophia Hober, Elham Rostami, Annica Rasmusson, View ORCID ProfileJanet L. Cunningham, Sebastian Havervall, Charlotte Thålin, Anna Månberg, View ORCID ProfilePeter Nilsson
doi: https://doi.org/10.1101/2024.02.15.24302857
August Jernbom Falk
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for August Jernbom Falk
Lovisa Skoglund
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
2Autoimmunity and Serology Profiling Unit, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Pin
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Sjöberg
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
2Autoimmunity and Serology Profiling Unit, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Tegel
3Department of Protein Science, Division of Protein Technology, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Hober
3Department of Protein Science, Division of Protein Technology, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elham Rostami
4Department of Medical Sciences, Section of Neurosurgery, Uppsala University Hospital, Uppsala, Sweden
5Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annica Rasmusson
6Department of Medical Sciences, Psychiatry, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet L. Cunningham
6Department of Medical Sciences, Psychiatry, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janet L. Cunningham
Sebastian Havervall
7Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Thålin
7Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Månberg
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Nilsson
1Department of Protein Science, Division of Affinity Proteomics, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Nilsson
  • For correspondence: peter.nilsson{at}scilifelab.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Autoantibodies have been shown to be implied in COVID-19 but the emerging autoantibody repertoire remains largely unexplored. We investigated the new-onset autoantibody repertoire in 525 healthcare workers and hospitalized COVID-19 patients in five time points over 16 months using proteome-wide and targeted protein and peptide arrays. Our results show that prevalent new-onset autoantibodies against a wide range of antigens emerged following SARS-CoV-2 infection in relation to pre-infectious baseline samples and remained elevated for at least 12 months. We demonstrated associations between distinct new-onset autoantibodies and neuropsychiatric symptoms post-COVID-19. Using epitope mapping, we determined the main epitopes of selected new-onset autoantibodies, validated them in independent cohorts of neuro-COVID and pre-pandemic healthy controls, and identified molecular mimicry between main epitopes and the conserved fusion peptide of the SARS-CoV-2 Spike glycoprotein. Our work describes the complexity and dynamics of the autoantibody repertoire emerging with COVID-19 and supports the need for continued analysis of the new-onset autoantibody repertoire to elucidate the mechanisms of the post-COVID-19 condition.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by a grant from the Swedish Research Council.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Swedish Ethical Review Authority gave ethical approval for this work under approval numbers: 2020-01653; 2021-04113; 2017-043 with amendments 2019-00169, 2020-01623, 2020-02719, 2020-05730, 2021-01469, and 2020-01883; 2014/148; and 2022-00526-01.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors and approval by the relevant ethical boards. Data cannot be shared freely as it contains sensitive personal data covered by the GDPR.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
August Jernbom Falk, Lovisa Skoglund, Elisa Pin, Ronald Sjöberg, Hanna Tegel, Sophia Hober, Elham Rostami, Annica Rasmusson, Janet L. Cunningham, Sebastian Havervall, Charlotte Thålin, Anna Månberg, Peter Nilsson
medRxiv 2024.02.15.24302857; doi: https://doi.org/10.1101/2024.02.15.24302857
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
August Jernbom Falk, Lovisa Skoglund, Elisa Pin, Ronald Sjöberg, Hanna Tegel, Sophia Hober, Elham Rostami, Annica Rasmusson, Janet L. Cunningham, Sebastian Havervall, Charlotte Thålin, Anna Månberg, Peter Nilsson
medRxiv 2024.02.15.24302857; doi: https://doi.org/10.1101/2024.02.15.24302857

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14638)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)